Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 124-42-5 | MDL No. : | MFCD00013016 |
Formula : | C2H7ClN2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | WCQOBLXWLRDEQA-UHFFFAOYSA-N |
M.W : | 94.54 | Pubchem ID : | 67170 |
Synonyms : |
|
Num. heavy atoms : | 5 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.5 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 24.99 |
TPSA : | 49.87 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.86 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 0.03 |
Log Po/w (WLOGP) : | 0.74 |
Log Po/w (MLOGP) : | 0.03 |
Log Po/w (SILICOS-IT) : | -0.59 |
Consensus Log Po/w : | 0.04 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 2.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.45 |
Solubility : | 33.9 mg/ml ; 0.359 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.63 |
Solubility : | 22.2 mg/ml ; 0.235 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | 0.18 |
Solubility : | 143.0 mg/ml ; 1.51 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.55 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
21% | With potassium carbonate In acetonitrile at 99.84℃; for 0.666667 h; Microwave irradiation; Sealed tube; Autoclave | General procedure: By following the general procedure at 373 K and by maintainingthat temperature for 40 min in the reaction with 2-bromo-1-phenylethanone [(1a); 200 mg, 1.01 mmol], 1H-imidazole (3a)(yield 16 mg, 20percent) was obtained as a white solid (m.p. 436–438 K). Recrystallization of this compound from methanol afforded colourless crystals suitable for X-ray diffractionanalysis. 1H NMR (400 MHz, CDCl3): 2.37 (s, 3H), 7.18 (s,1H), 7.20 (t, J = 7.3 Hz, 1H), 7.32 (t, J = 7.6 Hz, 2H), 7.66 (d, J =7.3 Hz, 2H), 8.76 (br s, 1H, NH). 13C{1H} NMR (100 MHz,CDCl3): 13.8 (CH3), 115.0 (CH), 124.6 (CH), 126.7 (CH),128.7 (CH), 132.7 (C), 137.7 (C), 145.2 (C). HRMS (ESI+):calculated for C10H11N2+ 159.0922 [M+H]+; found 159.0921. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
83% | With sodium hydroxide In water at -5 - 20℃; | Preparation of 2-(3-Methyl[1,2,4]thiadiazol-5-yl)octanedioic Acid 8-Hydroxyamide 1-Phenylamide (Compound 67022.6, which is Also Referred to as Compound 2021032 Below) The overall reaction scheme is as follows: Preparation of 5-Chloro-3-methyl-1,2,4-thiadiazole (2009380) To a stirred mixture of acetamidine hydrochloride (38.1 g, 0.40 mol) and trichloromethanesulfenyl chloride (75 g, 0.40 mol) at +-5° C. was added dropwise over 2.5 h a solution of NaOH (75.7 g, 0.40 mol) in water (126 mL). The resultant reaction mixture was then stirred at 0° C. for 30 min before being allowed to warm to room temperature. The mixture was subsequently filtered, the layers were separated, and the aqueous phase was extracted with dichloromethane (3*150 mL). The combined organic fractions were washed with brine (2*150 mL), dried (MgSO4), and the solvent was removed under reduced pressure to afford 5-chloro-3-methyl-1,2,4-thiadiazole (2009380) (43 g, 83percent) as a dark oil. |
41.8% | With sodium hydroxide In dichloromethane; water at -5℃; for 0.5 h; | To a mixture of perchloromethyl mercaptan (Gl) (60 g, 323 mmol) and acetamidine hydrochloride (30.6 g, 323 mmol) in dichloromethane(200 mL) was added dropwise a solution of NaOH (64.8 g in water (200 mL) at -5 0C. The resulting mixture was stirred at -5 0C for 30 min and then allowed to warm to room temperature. The organic layer was separated and the aqueous phase was extracted with dichloromethane (30 mL x 3). The combined organic layers were washed with water (50 mL x 2) and brine (100 mL), dried over Na2SO^ and the solvent was removed. The residue was distilled under reduced pressure to give 5-chloro-3-methyl-l,2,4- thiadiazole (G2) (bp 700C /0.85 Mpa, 18 g, 41.8percent). 1H-NMR (300 MHz, CDCl3) δ 2.59 (s, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
85% | With copper(l) iodide; TPGS-450-M; caesium carbonate In water at 20℃; for 12 h; Inert atmosphere; Green chemistry | General procedure: A two-neck round bottom flask was charged with a magnetic stirrer, evacuated and backfilled with nitrogen. Substituted 2-halobenzoic acid (1, 0.5 mmol) and amidine hydrochloride (2, 0.75 mmol) or bis(guanidine) sulphate (2, 0.38 mmol) in 2 wt percent TPGS-750-M (3 mL) were added under nitrogen atmosphere. After a 10-min stirring, Cs2CO3 (1 mmol, 326 mg) was added to the flask. 15 min later, CuI (0.1 mmol, 19 mg) was added to the flask. The mixture was allowed to stir under nitrogen atmosphere at the shown temperature for 12 h (see Table 3 in text). After completion of the reaction, the mixture was extracted with EtOAc (1 mL), and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel using petroleum ether/ethyl acetate (3:1 to 1:1) as eluent to provide the desired product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
42% | Stage #1: With sodium ethanolate In ethanol at 50℃; Stage #2: With sodium ethanolate In ethanol |
Step 42a: 5-Bromo-2-methylpyrimidine (Compound 0601-120)Sodium (356 mg, 15.5 mmol) was carefully added to ethanol (5.9 mL) to prepare sodium ethoxide solution in ethanol. The above freshly prepared sodium ethoxide in ethanol solution (3.5 mL) was added to a stirred suspension of acetamidine hydrochloride (0.91 g, 9.69 mmol). The mixture was warmed to 50 °C, then the heating bath was removed and a solution of mucobromic acid (1 g, 3.87 mmol) in ethanol was added dropwise at a rate which maintained a constant temperature, followed by a further sodium ethoxide in ethanol solution (2 mL). After cooling, the mixture was filtered and evaporated to a residue which was shaken vigorously with hydrochloric acid (2 M x 2.4 mL). The brown precipitate was filtered and washed with cold water, then freeze-dried to give 5-bromo-2- methylpyrimidine-4-carboxylic acid (350 mg, 42percent) as a brown solid. LCMS: 218 [M+l]+, 1H NMR (400 MHz, DMSO-d6): δ 2.62 (s, 3H), 9.03 (s, 1H). |
42% | at 50℃; | Step 42a: 5-Bromo-2-methylpyrimidine (Compound 0601-120)[0365]Sodium (356 mg, 15.5 mmol) was carefully added to ethanol (5.9 mL) to prepare sodium ethoxide solution in ethanol. The above freshly prepared sodium ethoxide in ethanol solution (3.5 mL) was added to a stirred suspension of acetamidine hydrochloride (0.91 g, 9.69 mmol). The mixture was warmed to 50° C., then the heating bath was removed and a solution of mucobromic acid (1 g, 3.87 mmol) in ethanol was added dropwise at a rate which maintained a constant temperature, followed by a further sodium ethoxide in ethanol solution (2 mL). After cooling, the mixture was filtered and evaporated to a residue which was shaken vigorously with hydrochloric acid (2 M×2.4 mL). The brown precipitate was filtered and washed with cold water, then freeze-dried to give 5-bromo-2-methylpyrimidine-4-carboxylic acid (350 mg, 42percent) as a brown solid. LCMS: 218 [M+1]+, 1H NMR (400 MHz, DMSO-d6): δ2.62 (s, 3H), 9.03 (s, 1H). |
42% | With sodium ethanolate In ethanol at 50℃; | Sodium (356mg, 15.5mmol) was added to the carefully ethanol (5.9mL), and in ethanolSodium ethoxide solution was prepared. Sodium ethoxide in freshly prepared ethanol solution of the above (3.5 mL) was added to a stirred suspension of acetamidine hydrochloride (0.91g, 9.69mmol). The mixture was allowed to warm up to 50 , and then the heating bath was removed, Mukoburomu acid (1g, 3.87mmol) a solution in ethanol, was dropped so that a constant temperature is maintained, then further, ethanol solution (2mL) sodium ethoxide was dropped of. After cooling, the mixture was filtered, and the residue was evaporated, stirred vigorously with hydrochloric acid (2Mx2.4mL). The brown precipitate was filtered, washed with cold water, and then to obtain a freeze-dried to give 5-bromo-2-methyl-pyrimidine-4-carboxylic acid (350mg, 42percent) as a brown solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
25.2% | With sodium ethanolate In ethanol at 20 - 50℃; for 17 h; | To a solution of the commercially available ethanimidamide ii, ashydrochloride, (6.0 g, 63.83 mmol) in anhydrous EtOH (20 mL) was added sodium ethoxide (20 mL of a 2i percent solution in ethanol) and the reactionmixture was stirred at 50 00 and the commercially available (2E)-2,3-dibromo-4-oxobut-2-enoic acid i 2 (6.82 g, 26.74 mmol) in EtOH (i 0 mL) was added into the mixture. After stirring at 50 00 for i hour, a further portion of sodiumethoxide (i 0 mL of a 2i percent solution in ethanol) was added and the mixture was stirred at r.t. for i6 h. The reaction mixture was filtrated and the filtratereduced in vacuo. The residue was then treated with 2 M aqueoushydrochloric acid (30 mL) and stirred vigorously for 30 mm. The resulting solid was filtrated, washed with water and air dried to give KR-i 3 (i .46 g, 25.2percent) as a pale yellow solid. ESI-MS (M+i): 2i7 calc. for C6H5BrN2O2:2i6.0. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
71% | With copper; sodium t-butanolate In N,N-dimethyl-formamide at 100℃; for 0.5 h; Microwave irradiation | General procedure: A 10 mL microwave reaction tube was charged with the appropriate β-bromo α,β-unsaturated carboxylic acid 1 (0.5mmol) and amidine hydrochloride 2 (1 mmol), together withCu powder (0.05 mmol), t-BuONa (2 mmol), and DMF (3mL). The mixture was heated to 100 °C for 30 min by microwave irradiation (CEM Discover Microwave System) at 100 W initial power. The mixture was then cooled to r.t.and filtered through a short column of silica gel (CHCl3–MeOH) to remove inorganic salts. Evaporation of the solvent gave a crude mixture that was purified by TLC [silica gel 60 GF254 (Merck), CHCl3–MeOH]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
81% | With copper(l) iodide; TPGS-450-M; caesium carbonate In water at 20℃; for 12 h; Inert atmosphere; Green chemistry | General procedure: A two-neck round bottom flask was charged with a magnetic stirrer, evacuated and backfilled with nitrogen. Substituted 2-halobenzoic acid (1, 0.5 mmol) and amidine hydrochloride (2, 0.75 mmol) or bis(guanidine) sulphate (2, 0.38 mmol) in 2 wt percent TPGS-750-M (3 mL) were added under nitrogen atmosphere. After a 10-min stirring, Cs2CO3 (1 mmol, 326 mg) was added to the flask. 15 min later, CuI (0.1 mmol, 19 mg) was added to the flask. The mixture was allowed to stir under nitrogen atmosphere at the shown temperature for 12 h (see Table 3 in text). After completion of the reaction, the mixture was extracted with EtOAc (1 mL), and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel using petroleum ether/ethyl acetate (3:1 to 1:1) as eluent to provide the desired product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
61% | Stage #1: at 0℃; for 0.333333 h; Stage #2: at 0℃; for 0.5 h; Stage #3: With triethylamine In ethanol for 2 h; Reflux |
(0294) To a solution of sodium (2.90 g, 126 mmol) in ethanol (150 mL) was added acetoamidine hydrochloride (11.9 g, 126 mmol) at 0° C. The mixture was stirred at 0° C. for 20 minutes, diethyl (ethoxymethylene)malonate (28.6 g, 132 mmol) was added dropwise thereto, the mixture was stirred at 0° C. for 30 minutes, and triethylamine (20 mL, 145 mmol) was added thereto. The mixture was heated under reflux for 2 hours, the reaction mixture was concentrated, water (400 mL) was added thereto, citric acid was added to adjust pH to 4 to 5, and the mixture was extracted with dichloromethane (200 mL) three times. The organic layers were combined, dried over anhydrous sodium sulfate, filtrated, and concentrated. To the resulting concentrated residue was added tert-butyl methyl ether (200 mL), and the precipitate was collected on a filter to give the title compound (14.0 g, 61percent) (0295) 1H-NMR (400 MHz, CDCl3) δ: 1.40 (3H, t, J=7.2 Hz), 2.61 (3H, s), 4.39 (2H, q, J=7.2 Hz), 8.73 (1H, s). |
27% | With hydrogenchloride In ethanol; dichloromethane; sodium ethanolate; ethyl acetate | EXAMPLE 30 Ethyl 2-methyl-pyrimidin-6(1H)-one-5-carboxylate STR55 Acetamidine hydrochloride (37.16 g, 0.39 mole) was stirred in sodium ethoxide in ethanol (73 mL of a 21percent solution, 0.20 mole) for 5 minutes. Diethyl ethoxymethylenemalonate (31.5 mL, 0.15 mole) was added, and the reaction mixture was refluxed for 5 hours. The reaction mixture was allowed to cool to room temperature overnight, and diluted with dichloromethane (100 mL). The solution was filtered, washing the solid cake with dichloromethane. The filtrate was concentrated at reduced pressure. The residue was dissolved in dichloromethane (150 mL) and 2.0N HCl (30 mL). The pH of the aqueous layer was 1. The organic layer was washed with water, saturated sodium bicarbonate and brine, dried over anhydrous magnesium sulfate, and the solvent was removed under reduced pressure. The residue was dissolved in hot dichloromethane (50 mL). Ethyl acetate was added (50 mL). The product precipitated. The solution was boiled for 5 minutes, cooled to room temperature, and hexanes were added (50 mL). The resulting crystals were filtered, then washed with ethyl acetate (20 mL) followed by hexanes (50 mL) to yield the title compound (7.22 g, 27percent) as off-white crystals. Rf =0.27 (silica gel, 10percent isopropanol in dichloromethane). The title compound also was prepared by the route described in Example 102. |
27% | With hydrogenchloride In ethanol; dichloromethane; sodium ethanolate; ethyl acetate | Example 30 Ethyl 2-methyl-pyrimidin-6(1H)-one-5-carboxylate STR57 Acetamidine hydrochloride (37.16 g, 0.39 mole) was stirred in sodium ethoxide in ethanol (73 mL of a 21percent solution, 0.20 mole) for 5 minutes. Diethyl ethoxymethylenemalonate (31.5 mL, 0.15 mole) was added, and the reaction mixture was refluxed for 5 hours. The reaction mixture was allowed to cool to room temperature overnight, and diluted with dichloromethane (100 mL). The solution was filtered, washing the solid cake with dichloromethane. The filtrate was concentrated at reduced pressure. The residue was dissolved in dichloromethane (150 mL) and 2.0N HCl (30 mL). The pH of the aqueous layer was 1. The organic layer was washed with water, saturated sodium bicarbonate and brine, dried over anhydrous magnesium sulfate, and the solvent was removed under reduced pressure. The residue was dissolved in hot dichloromethane (50 mL). Ethyl acetate was added (50 mL). The product precipitated. The solution was boiled for 5 minutes, cooled to room temperature, and hexanes were added (50 mL). The resulting crystals were filtered, then washed with ethyl acetate (20 mL) followed by hexanes (50 mL) to yield the title compound (7.22 g, 27percent) as off-white crystals. Rf =0.27 (silica gel, 10percent isopropanol in dichloromethane). The title compound also was prepared by the route described in Example 102. |
27% | With hydrogenchloride In ethanol; dichloromethane; sodium ethanolate; ethyl acetate | Example 30 Ethyl 2-methyl-pyrimidin-6(1H)-one-5-carboxylate STR52 Acetamidine hydrochloride (37.16 g, 0.39 mole) was stirred in sodium ethoxide in ethanol (73 mL of a 21percent solution, 0.20 mole) for 5 minutes. Diethyl ethoxymethylenemalonate (31.5 mL, 0.15 mole) was added, and the reaction mixture was refluxed for 5 hours. The reaction mixture was allowed to cool to room temperature overnight, and diluted with dichloromethane (100 mL). The solution was filtered, washing the solid cake with dichloromethane. The filtrate was concentrated at reduced pressure. The residue was dissolved in dichloromethane (150 mL) and 2.0N HCl (30 mL). The pH of the aqueous layer was 1. The organic layer was washed with water, saturated sodium bicarbonate and brine, dried over anhydrous magnesium sulfate, and the solvent was removed under reduced pressure. The residue was dissolved in hot dichloromethane (50 mL). Ethyl acetate was added (50 mL). The product precipitated. The solution was boiled for 5 minutes, cooled to room temperature, and hexanes were added (50 mL). The resulting crystals were filtered, then washed with ethyl acetate (20 mL) followed by hexanes (50 mL) to yield the title compound (7.22 g, 27percent) as off-white crystals. Rf =0.27 (silica gel, 10percent isopropanol in dichloromethane). The title compound also was prepared by the route described in Example 102. |
27% | With hydrogenchloride In ethanol; dichloromethane; sodium ethanolate; ethyl acetate | Example 30 Ethyl 2-Methyl-pyrimidin-6(1H)-one-5-carboxylate STR50 Acetamidine hydrochloride (37.16 g, 0.39 mole) was stirred in sodium ethoxide in ethanol (73 mL of a 21percent solution, 0.20 mole) for 5 minutes. Diethyl ethoxymethylenemalonate (31.5 mL, 0.15 mole) was added, and the reaction mixture was refluxed for 5 hours. The reaction mixture was allowed to cool to room temperature overnight, and diluted with dichloromethane (100 mL). The solution was filtered, washing the solid cake with dichloromethane. The filtrate was concentrated at reduced pressure. The residue was dissolved in dichloromethane (150 mL) and 2.0N HCl (30 mL). The pH of the aqueous layer was 1. The organic layer was washed with water, saturated sodium bicarbonate and brine, dried over anhydrous magnesium sulfate, and the solvent was removed under reduced pressure. The residue was dissolved in hot dichloromethane (50 mL). Ethyl acetate was added (50 mL). The product precipitated. The solution was boiled for 5 minutes, cooled to room temperature, and hexanes were added (50 mL). The resulting crystals were filtered, then washed with ethyl acetate (20 mL) followed by hexanes (50 mL) to yield the title compound (7.22 g, 27percent) as off-white crystals. Rf =0.27 (silica gel, 10percent isopropanol in dichloromethane). The title compound also was prepared by the route described in Example 102. |
27% | With sodium ethanolate In ethanol for 5 h; Heating / reflux | Acetamidine hydrochloride (37.16 g, 0.39 mole) was stirred in sodium ethoxide in ethanol (73 ML of a 21percent solution, 0.20 mole) for 5 minutes.. diethyl ethoxymethylenemalonate (31.5 ML, 0.15 mole) was added, and the reaction mixture was refluxed for 5 hours.. The reaction mixture was allowed to cool to room temperature overnight, and diluted with dichloromethane (100 ML).. The solution was filtered, washing the solid cake with dichloromethane.. The filtrate was concentrated at reduced pressure.. The residue was dissolved in dichloromethane (150 ML) and 2.0N HCl (30 ML).. The PH of the aqueous layer was 1.. The organic layer was washed with water, saturated sodium bicarbonate and brine, dried over anhydrous magnesium sulfate, and the solvent was removed under reduced pressure.. The residue was dissolved in hot dichloromethane (50 ML).. ethyl acetate was added (50 ML).. The product precipitated.. The solution was boiled for 5 minutes, cooled to room temperature, and hexanes were added (50 ML).. The resulting crystals were filtered, then washed with ethyl acetate (20 ML) followed by hexanes (50 ML) to yield the title compound (7.22 g, 27percent) as off-white crystals. Rf=0.27 (silica gel, 10percent isopropanol in dichloromethane).. The title compound also was prepared by the route described in Example 102. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
84% | With potassium hydroxide In methanol; (2S)-N-methyl-1-phenylpropan-2-amine hydrate | EXAMPLE 2 Acetamidine hydrochloride (9.5 g) was added to a predissolved solution of methanol (50 mL) and KOH pellets (6.8 g) at 10° C. It was then dropped into a solution of 11.4 g of dimethyl N-cyanoimidocarbonate and 40 mL of methanol at 10° C. After the addition, the reaction mixture was stirred at 25° C. for 2 hours onto 40 mL of ice water. The solid crystals were collected by filtering and washing with water and methanol. After drying at 70° C. overnight, 11.8 g (84percent yield) of 2-methyl-4-amino-6-methoxy-1,3,5-triazine was obtained. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
36% | With sodium ethanolate In ethanol for 20 h; Reflux | 2,6-dimethylpyrimidin-4-ol. Ethyl 3-oxobutanoate (10.0 g, 77 mmol) and acetimidamide hydrochloride (7.23 g, 77 mmol) were added to the solution of sodium ethanolate (10.5 g, 154 mmol) in ethanol (200 mL). And the mixture was refluxed for 20 hours. Water (10 mL) was added to the mixture. The resultant mixture was concentrated to give a residue. The residue was purified by column chromatography (silica gel, dichloromethane /methanol = 15: 1) to give 2,6-dimethylpyrimidin-4-ol as a yellow solid (3.43 g, 36percent). LRMS (M + H+) m/z: calcd 124.06; found 124. |
29% | With potassium carbonate In water at 20℃; for 0.25 h; Microwave irradiation | General procedure: The corresponding amidine hydrochloride (2.54 mmol) and powdered K2CO3 (5.76 mmol) were dissolved in water (5.0 mL) in a 20-mL vessel. The β-keto ester (2.31 mmol) was added and the resulting mixture was irradiated for 5–15 min (see Table 2). Upon the end of the reaction (TLC, hexanes/EtOAc, 5:1), the mixture was diluted with sat. aq NH4Cl (5.0 mL) and extracted with CH2Cl2 (3 × 15 mL). The combined organic phases were dried (anhyd Na2SO4) and filtered. The filtrate was rotary evaporated and the obtained crude product was purified by column chromatography [silica gel, hexane/EtOAc mixtures or recrystallized (EtOH)]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
10 g | With sodium In ethanol for 5 h; Reflux | To 500 mL of EtOH was added sodium (12 g, 0.50 mol) in portions at room temperature and the resulting mixture was stirred until the sodium was dissolved completely. To a suspension of the previously prepared salt (60 g, 0.17 mol) and acetamidine hydrochloride (17.4 g, 0.19 mol) in EtOH (2.5 L) was added the above solution at room temperature and the resulting mixture was heated to reflux for 5 h. After filtration, the solvent was removed under reduced pressure to give the remains, which was suspended in H2O (200 mL) and extracted with DCM (3 mL×100). The organic layer was washed with brine, dried over Na2SO4 and concentrated. The crude product was purified by column chromatography on silica gel (petroleum ether: EtOAc=5:1 to 2:1) to afford 2-methyl-pyrimidine-5-carbaldehyde (10 g, yield: 50percent). 1H NMR (CDCl3 400 MHz): δ10.10 (s, 1H), 9.07 (s, 2H), 2.84 (s, 3H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | Stage #1: With sodium methylate In methanol at 20℃; Stage #2: With hydrogenchloride In water |
Part A: 5-Fluoro-4,6-dihydroxy-2-methylpyrimidine. A solution of 200 ml. of 25percent wt sodium methoxide in methanol (0.84 mol) was diluted with an additional 200 ml. of methanol. Acetamidine-HCI (40 g , 0.42 mol) was added to the sodium methoxide solution (white precipitate formed), followed by addition of dimethyl fluoromalonate (70 g, 0.46 mol). The contents were stirred at room temperature overnight, then concentrated in vacuo to dryness. The resulting residue was redissolved in hot water (300 ml_). After cooling the aqueous solution to room temperature, concentrated HCI was added slowly until crystal formation (fine white prisms) took place at about pH 5. Concentrated HCI was added dropwise until pH 3, and then the contents were filtered. The isolated crystals were rinsed with 1 M HCI and dried under vacuum to provide 5-fluoro-4,6-dihydroxy-2-methylpyrimidine (65.5 g, >100percent). LCMS: (M+H)+: 145. |
65.5 g | at 20℃; Inert atmosphere | Part A: 5-Fluoro-4,6-dihydroxy-2-methylpyrimidine A solution of 200 ml. of 25percent wt sodium methoxide in methanol (0.84 mol) was diluted with an additional 200 ml. of methanol. Acetamidine-HCI (40 g , 0.42 mol) was added to the sodium methoxide solution (white precipitate formed), followed by addition of dimethyl fluoromalonate (70 g, 0.46 mol). The contents were stirred at room temperature overnight, then concentrated in vacuo to dryness. The resulting residue was redissolved in hot water (300 ml_). After cooling the aqueous solution to room temperature, concentrated HCI was added slowly until crystal formation (fine white prisms) took place at about pH 5. Concentrated HCI was added dropwise until pH 3, and then the contents were filtered. The isolated crystals were rinsed with 1 M HCI and dried under vacuum to provide 5-fluoro-4,6-dihydroxy-2-methylpyrimidine (65.5 g, >100percent). LCMS: (M+H)+: 145. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
64% | Stage #1: at 20℃; for 3 h; Heating / reflux Stage #2: at 20℃; for 1 h; |
Part A: A mixture of sodium metal (1.55 g, 67.4 mmol) and EtOH (15.0 mL, 257 mmol) was stirred at RT until nearly all sodium had reacted. Diethyl fluoromalonate (3.54 mL, 22.4 mmol) was added followed by acetamidine hydrochloride (2.14 g, 22.7 mmol). The reaction mixture was heated at reflux for 3 h, cooled to RT and concentrated under reduced pressure. The residue was diluted with water (ca. 50 mL) and acidified (pH=2) with 6M aqueous HCl, and the mixture was stirred at RT for 1 h as a precipitate formed. The solids were collected by suction filtration and washed with water. Excess solvent was removed in vacuo to give 4,6-dihydroxy-5-fluoro-2-methylpyrimidine (2.08 g, 64percent) as a light gray solid. LCMS (m/z): 145 (M+H)+ |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With sodium methylate In methanol at 25℃; for 20 h; Inert atmosphere | General procedure: To a solution of sodium methoxide (25 wt-percent in methanol) (67.6 mL, 296 mmol) and methanol (70 mL) at 25 °C was added formamidine acetate (11.00 g, 106 mmol) and then ethyl N-benzyl-3-oxo-4-piperidine carboxylate hydrochloride (25.16 g, 84 mmol). The resulting mixture was stirred at 25 °C for 20 h. The mixture was cooled to 0 °C. Water (90mL) was added, followed by the dropwise addition of acetic acid (6.05 mL, 106 mmol), and the reaction mixture was stirred at 25 °C for another 3 h. The mixture was reduced in volume under vacuum until most of the methanol had been removed. The suspension was filtered. The solids were washed with water and thendried under vacuum to afford 7-benzyl-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4(3H)-one (16.10 g, 79 percent) as an off-white solid; LC/MS:m/z 242.06 (M + H)+, 0.598 min (method 12). 1H-NMR (500 MHz, CDCl3) δ12.61 (br s, 1 H), 7.99 (s, 1 H), 7.38-7.26 (m, 5 H),3.73 (m, 2 H), 3.50 (m, 2 H), 2.74 (m, 2 H), 2.66 (m, 2 H). |
77% | With sodium ethanolate In ethanol for 16 h; Heating / reflux | Example 51Preparation of Compounds 211, 215, 216, 225, 226 and 231Compounds 211, 215, 216, 225, 226 and 231 were prepared using the method set forth below. <n="193"/>Step A - Synthesis of7-benzyl-2-methyl-5,6, 7,8-tetrahydro-3H-pyrido[3,4-d]pyrimidin-4-oneTo a solution of l-benzyl-3-oxo-piperidine-4-carboxylic acid ethyl ester hydrochloride (5.0 g, 16.8 mmol) in 80 mL ethanol was added acetamidine hydrochloride (2.4 g, 25.2 mmol) followed by sodium ethoxide (21percent in ethanol, 10.6 mL, 33.6 mmol). The resulting reaction was heated to reflux and allowed to stir at this temperature for 16 hours. The reaction was then cooled to room temperature, diluted with dichloromethane, and the organic phase was washed with water and brine, dried and concentrated in vacuo, the resulting residue was purified using flash column chromatography (5percent methanol in dichloromethane) to provide 7-benzyl-2- methyl-5,6,7,8-tetrahydro-3H-pyrido[3,4-d]pyrimidin-4-one in 77percent yield. |
95% | With sodium ethanolate In ethanol; water; acetic acid | Step A: 7-Benzyl-2-methyl-5,6,7,8-tetrahydro-3H-pyrido[3,4-d]pyrimidin-4-one A solution of sodium ethoxide in ethanol was prepared by addition of sodium metal (5.7 g, 247 mmol) to absolute ethanol (141 mL). After the sodium metal had all dissolved, ethyl 1-benzyl-3-oxo-4-piperidine carboxylate hydrochloride (21 g, 70.5 mmol) was added followed by acetamidine hydrochloride (13.3 g, 141 mmol). This mixture was stirred at reflux for 1 h, cooled to room temperature, and concentrated. The residue was dissolved in a minimum amount of water and the pH was adjusted to about 7 with glacial acetic acid. The resulting yellow precipitate was filtered, washed with water (3*), air-dried for 2 h, then vacuum-dried overnight to provide 17.1 g (95percent) of the title compound of Example 86, Step A as a yellow solid. 1H NMR (CDCl3, 250 MHz) δ7.35-7.25 (c, 5H), 3.70 (s, 2H), 3.42 (s, 2H), 2.73-2.64 (c, 2H), 64-2.60 (c, 2H), 2.41 (s, 3H); MS (APCI) 256 (MH+). |
[ 3599-89-1 ]
Propionimidamide hydrochloride
Similarity: 0.71
[ 10300-69-3 ]
2-Chloroacetimidamide hydrochloride
Similarity: 0.71
[ 39254-63-2 ]
Acetimidohydrazide hydrochloride
Similarity: 0.67
[ 54198-71-9 ]
2-Hydroxyacetimidamide hydrochloride
Similarity: 0.63
[ 3599-89-1 ]
Propionimidamide hydrochloride
Similarity: 0.71
[ 10300-69-3 ]
2-Chloroacetimidamide hydrochloride
Similarity: 0.71
[ 39254-63-2 ]
Acetimidohydrazide hydrochloride
Similarity: 0.67
[ 54198-71-9 ]
2-Hydroxyacetimidamide hydrochloride
Similarity: 0.63
[ 22007-68-7 ]
Isobutyrimidamide hydrochloride
Similarity: 0.59
[ 3599-89-1 ]
Propionimidamide hydrochloride
Similarity: 0.71
[ 10300-69-3 ]
2-Chloroacetimidamide hydrochloride
Similarity: 0.71
[ 39254-63-2 ]
Acetimidohydrazide hydrochloride
Similarity: 0.67
[ 54198-71-9 ]
2-Hydroxyacetimidamide hydrochloride
Similarity: 0.63